GOLDENWELL BIOTECH, INC. Annual Net Income (Loss) Attributable to Parent in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Goldenwell Biotech, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2019 to 2023.
  • Goldenwell Biotech, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$49.9K, a 84.3% decline year-over-year.
  • Goldenwell Biotech, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$137K, a 86.1% increase year-over-year.
  • Goldenwell Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$117K, a 88.1% increase from 2022.
  • Goldenwell Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$985K, a 742% decline from 2021.
  • Goldenwell Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$117K, a 1750% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$117K +$868K +88.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-12
2022 -$985K -$868K -742% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-12
2021 -$117K -$111K -1750% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-13
2020 -$6.32K -$4.01K -174% Jan 1, 2020 Dec 31, 2020 10-K/A 2023-02-06
2019 -$2.31K Jan 1, 2019 Dec 31, 2019 10-K 2021-07-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.